History of severe asthma or absolute requirement for chronic inhaled corticosteroid medications.
Hx of drug-related anaphylactic reactions, severe allergic reactions related to drug; active diagnosis of uncontrolled airway hyperactivity, uncontrolled asthma, or asthma requiring oral corticosteroids.
Pulmonary disease (e.g. COPD, asthma, etc) that is not controlled (moderate to severe symptoms) with current medication
Moderate or severe persistent asthma, or a history of asthma within the last 2 years, or currently has uncontrolled asthma of any classification
Subject has known moderate or severe persistent asthma within the past 2 years or currently has uncontrolled asthma of any classification\r\n* Subjects who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed in the study
Patients must not have aspirin sensitive asthma
Other significant or uncontrolled medical illness; patients with a remote history of asthma or active mild asthma may participate
Known chronic obstructive pulmonary disease (COPD) (defined as a forced expiratory volume in 1 second [FEV1] < 50% of predicted normal), persistent asthma, or a history of poorly controlled asthma within the last 2 years (controlled intermittent asthma or controlled mild persistent asthma is allowed)
History of severe asthma or absolute requirement for chronic inhaled corticosteroid medications (subjects with a history of mild asthma that are on or can be switched to noncorticosteroid bronchodilator regimens are eligible)
Pulmonary disease (e.g. COPD, asthma, etc) that is not controlled (moderate to severe symptoms) with current medication
Severe asthma.
History of severe asthma and currently on chronic systemic medications (mild asthma requiring inhaled steroids only is eligible)
Currently being treated with bronchodilators or corticosteroids or known to have active asthma. This will not include patients who suffered from asthma as a child and outgrew it.
History of severe asthma and currently on chronic systemic medications (mild asthma requiring inhaled steroids only is eligible)
History of severe asthma and currently on systemic chronic medications (mild asthma requiring inhaled steroids only is eligible)
History of severe asthma, presently on chronic medications (a history of mild asthma requiring inhaled steroids only is eligible)
Known moderate or severe persistent asthma within the past 2 years, or uncontrolled asthma of any classification. Note that subjects who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed to participate in the study.
History of asthma that is nonsteroidal anti-inflammatory drug (NSAID)-induced or with asthma that is classified as ‘mild-persistent’ or worse (based on symptoms occurring more than 2 days per week)
History of severe asthma or presently on chronic inhaled corticosteroid medications (patients with a history of mild asthma not requiring corticosteroid therapy are eligible)
Known severe hypersensitivity reactions to monoclonal antibodies (Grade ?3), any history of anaphylaxis, or uncontrolled asthma (ie, 3 or more features of partially controlled asthma Global Initiative for Asthma 2011)
Patients with a history of asthma will be excluded
Evidence of active autoimmune disease (e.g., systemic lupus erythematosis, rheumatoid arthritis, with the exception of vitiligo. Patients with a remote history of asthma or mild asthma are eligible.
Known moderate or severe persistent asthma within the past 2 years, or uncontrolled asthma of any classification
Criteria 6 Known moderate or severe persistent asthma within the past 2 years
History of severe asthma and currently on chronic systemic medications (mild asthma requiring inhaled steroids only is eligible)
Other significant or uncontrolled medical illness; patients with a remote history of asthma or active mild asthma may participate
Subject has known moderate or severe persistent asthma within 2 years, or currently has uncontrolled asthma of any classification; (Note that subjects who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed in the study)
History of severe asthma and currently on systemic chronic medications (mild asthma requiring inhaled steroids only is eligible)
Subject has known moderate or severe persistent asthma within the past 2 years, or currently has uncontrolled asthma of any classification. NOTE: subjects who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed in the study
History of severe asthma, as defined by prior or current use of systemic corticosteroids for disease control, with the exception of physiological replacement doses of cortisone acetate or equivalent, as defined by a dose of 10 mg or less; note: a history of mild asthma not requiring therapy is eligible
History of severe asthma, presently on chronic medications (a history of mild asthma not requiring therapy is eligible)
Known moderate or severe persistent asthma within the past 2 years or currently has uncontrolled asthma of any classification
Participant has known chronic obstructive pulmonary disease (COPD) (defined as a forced expiratory volume in 1 second [FEV1] <50% of predicted normal), persistent asthma, or a history of asthma within the last 2 years (controlled intermittent asthma or controlled mild persistent asthma is allowed)
Has moderate or severe persistent asthma within the past 2 years or uncontrolled asthma of any classification.
Known chronic obstructive pulmonary disease, persistent asthma, or a history of asthma within 2 years
Patients with a remote history of asthma or active mild asthma may participate.
Participant has known chronic obstructive pulmonary disease (COPD) (defined as a forced expiratory volume in 1 second [FEV1] <50% of predicted normal), known moderate or severe persistent asthma within the last 2 years or currently has uncontrolled asthma of any classification (controlled intermittent asthma or controlled mild persistent asthma is allowed)
Evidence of active autoimmune disease (e.g., systemic lupus erythematosis, rheumatoid arthritis, with the exception of vitiligo. Patients with a remote history of asthma or mild asthma are eligible.
History of asthma
Autoimmune disease (e.g., systemic lupus erythematosis (SLE), rheumatoid arthritis (RA), etc.). Patients with a remote history of asthma or mild active asthma are eligible.
Autoimmune disease (e.g., systemic lupus erythematosis (SLE), rheumatoid arthritis (RA), etc.). Patients with a remote history of asthma or mild active asthma are eligible.
History of severe asthma or presently on chronic inhaled corticosteroid medications (patients with a history of mild asthma controlled with inhaled bronchodilators are eligible)
Moderate to end-stage kidney disease and a history of severe asthma or allergies
History of severe asthma, presently on chronic medications (a history of mild asthma not requiring therapy is eligible)
Participant has known chronic obstructive pulmonary disease (COPD) with a Forced Expiratory Volume in 1 second (FEV1) less than (<) 50% predicted normal. Note that FEV1 testing is required for participants suspected of having COPD and participants must be excluded if FEV1 <50% b) Participant has known moderate or severe persistent asthma within 2 years (see Attachment 4: NHLBI table of asthma severity), or currently has uncontrolled asthma of any classification. (Note that participants who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed in the study)
Autoimmune disease (e.g., systemic lupus erythematosis (SLE), rheumatoid arthritis (RA), etc.). Patients with a remote history of asthma or mild active asthma are eligible.
Conditions requiring chronic systemic glucocorticoid use, such as autoimmune disease or severe asthma, excluding inhalation steroids for maintenance.
Chronic ongoing oral steroid use at the time of registration for any condition (such as asthma, rheumatoid arthritis, etc)
History of drug-related anaphylactic reactions or allergic reactions; subjects with an active diagnosis of uncontrolled airway hyperactivity, uncontrolled asthma, or asthma requiring oral corticosteroids will be excluded
History of asthma
No history of severe asthma, as defined by prior or current use of systemic corticosteroids for disease control, with the exception of physiological replacement doses of cortisone acetate or equivalent, as defined by a dose of 10 mg or less; NOTE: history of mild asthma not requiring daily therapy is eligible
History of severe asthma, presently on chronic medications (a history of mild asthma not requiring therapy is eligible)
Patients must not have uncontrolled asthma
Asthma or other reactive airway disease
History or current clinical evidence of moderate -to-severe obstructive pulmonary disease or reactive airway diseases (i.e.: asthma) requiring therapy
No history of bronchial asthma or related bronchospastic conditions
Prior history of (H/O) severe allergy or asthma requiring active treatment
Participants with persistent asthma as defined by the National Heart, Lung, and Blood Institute.
Participants with persistent asthma as defined by the National Heart, Lung, and Blood Institute
History or current clinical evidence of moderate-to-severe obstructive pulmonary disease or reactive airway diseases (i.e. asthma) requiring therapy
Adult asthma
History of severe asthma and currently on chronic systemic medications (mild asthma requiring inhaled steroids only is eligible)
Clinical diagnosis of asthma
Adult asthma
Participants with persistent asthma as defined by the National Heart, Lung, and Blood Institute
Asthma, wheezing or breathing problems
History of chronic asthma
Patient must not have a history of allergy or bronchial asthma
Uncontrolled asthma or asthma requiring oral corticosteroids.
